RxDoctor Payments DataLook up a doctor →

Diane Sutter, MD

Gynecology · Kenmore, NYNPI 1447291703

Payments from drug & device makers

$94,774in general payments, 2019–2025

Across 1,154 payments — averaging $82.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$39K
  • Pfizer$16K
  • AbbVie$10K
  • Myovant Sciences Inc.$8K
  • AMAG Pharmaceuticals, Inc.$6K
  • Therapeuticsmd, Inc.$4K
  • plus $13K from 52 others

What the payments were for

  • Speaking & faculty fees$69,73074%
  • Travel & lodging$5,5186%
  • Food & beverage$18,76820%
  • Education$7571%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc130$38,715
Pfizer135$15,721
AbbVie(2 entities)120$10,352
Myovant Sciences Inc.25$7,629
AMAG Pharmaceuticals, Inc.40$5,903
Therapeuticsmd, Inc.56$3,900
Sumitomo Pharma America, Inc.68$2,112
Mayne Pharma Commercial LLC56$1,452
Amgen91$1,411
Novo Nordisk66$1,200
Axsome Therapeutics, Inc.11$648
Radius Health, Inc.15$482
Lilly USA, LLC22$477
Avion Pharmaceuticals39$387
Takeda Pharmaceuticals U.S.A., Inc.58$373
Agile Therapeutics, Inc.27$350
Idorsia Pharmaceuticals US Inc16$273
Astellas Pharma Global Development3$252
Exeltis, USA Inc.13$226
Daiichi Sankyo Inc.9$213
Biohaven Pharmaceuticals, Inc.9$203
Exact Sciences12$169
Eisai Inc.10$148
Scynexis, Inc.8$146
Ascend Therapeutics US, LLC7$141
Millicent US Inc7$138
Upsher-smith Laboratories LLC7$127
Shield Therapeutics Inc7$127
Lupin Inc.7$113
Amarin Pharma, Inc.7$110
Alfasigma USA, Inc.7$109
Mylan Pharmaceuticals Inc.6$105
Coopersurgical, Inc.4$97
Amneal Pharmaceuticals LLC3$87
Vertical Pharmaceuticals, LLC5$85
Biohaven Pharmaceutical Holding Company Ltd.4$80
Kowa Pharmaceuticals America, Inc.4$80
Merck5$78
Almatica Pharma LLC2$54
Organon3$52
Hologic Sales And Service, LLC2$43
Teva Pharmaceuticals USA, Inc.3$43
AstraZeneca2$37
Roche Diagnostics Corporation2$35
Zyla Life Sciences, Inc.2$34
Phathom Pharmaceuticals, Inc.5$30
Urovant Sciences Inc2$29
Johnson & Johnson2$28
Oyster Point Pharma, Inc.1$23
Esperion Therapeutics, Inc.1$22
Virtus Pharmaceuticals LLC1$20
Bayer1$16
Ironwood Pharmaceuticals, Inc1$16
Covis Pharma GmbH1$16
Medtronic1$16
Cosette Pharmaceuticals Inc.1$15
Evofem Biosciences, Inc.1$14
Impel Pharmaceuticals Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$94,774 in reported general payments places this provider in the 95th percentile of 240 gynecology providers in New York.

See all gynecology providers in New York

Medicare billing

Part B allowed, 2024
$13,175
Medicare patients
121
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron80$73,121
GemtesaVibegron70$71,420
VascepaIcosapent Ethyl81$66,665
Icosapent Ethyl116$53,896
OzempicSemaglutide45$48,389
PremarinEstrogens, Conjugated106$47,026
DottiEstradiol226$40,927
TrintellixVortioxetine Hydrobromide50$40,400
Estradiol (Twice Weekly)Estradiol236$40,307
EstringEstradiol68$34,763
TymlosAbaloparatide13$34,115
MounjaroTirzepatide29$29,482
Estradiol241$26,057
Teriparatide13$25,820
VeozahFezolinetant32$19,241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq, Veozah$38,715$92,363112 claims
PfizerPremarin, Estring$15,721$81,789174 claims
Sumitomo Pharma America, Inc.Gemtesa$2,112$71,42070 claims
Novo NordiskOzempic$1,200$48,38945 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$373$40,40050 claims
Radius Health, Inc.Tymlos$482$34,11513 claims
Lilly USA, LLCMounjaro$477$29,48229 claims
AMAG Pharmaceuticals, Inc.Intrarosa$5,903$13,92923 claims
Therapeuticsmd, Inc.Imvexxy$3,900$12,16325 claims
Eisai Inc.Dayvigo$148$10,49418 claims
Millicent US IncFemring$138$9,52313 claims
Exeltis, USA Inc.Evamist$226$3,28712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 240 gynecology providers in New York.

Other gynecology in Kenmore

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →